NHS

News

NICE backs NHS use of Autolus' leukaemia CAR-T

Hundreds of people with an aggressive leukaemia will be able to access a CAR-T therapy developed by UK biotech Autolus after a NICE recommendation.

Patients

doctor with atlas superimposed across his chest

Overseas doctors are keeping the NHS alive: It’s time we sto...

As a loud minority pushes Britain towards devolved nationalism, it’s worth remembering this sobering truth: without immigrants, there would be no NHS.

News

Alnylam's ATTR cardiomyopathy drug backed for NHS use

Patients with ATTR-CM in England and Wales will soon have a new treatment option, after NICE backed use of Alnylam's three-month injectable Amvuttra.

Market Access

Why the NHS remains the world's most challenging – and rewar...

For pharmaceutical, biotech, and medtech companies eyeing global expansion, the NHS presents a paradox.

News

NICE backs five AI tools for bowel cancer screening

Five AI technologies used during a colonoscopy exam to help detect the early signs of bowel cancer have been backed for use by the NHS in England.

News

NICE backs Roche's non-Hodgkin lymphoma drug Columvi

NICE backs NHS use of Roche's Columvi as a second-line therapy for a form of non-Hodgkin lymphoma affecting thousands of people in the UK each year.

NICE backs NHS use of Autolus' leukaemia CAR-T

Overseas doctors are keeping the NHS alive: It’s time we sto...

Alnylam's ATTR cardiomyopathy drug backed for NHS use

Why the NHS remains the world's most challenging – and rewar...

NICE backs five AI tools for bowel cancer screening

NICE backs Roche's non-Hodgkin lymphoma drug Columvi

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

NHS

Editor's Picks